That view is shared by Alan Gardner,
head of the securities litigation practice at Bennett Jones LLP in Toronto.
Wendy Berman is
the head of the securities litigation and white collar crime and regulatory response groups at Cassels Brock.
Not exact matches
These risks and uncertainties include, among others: the unfavorable outcome
of litigation, including so - called «Paragraph IV»
litigation and other patent
litigation, related to any
of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components
of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence
of efficacy and adequacy
of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results
of our clinical development activities may not be positive, or predictive
of real - world results or
of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights
of third parties, or have unintended side effects, adverse reactions or incidents
of misuse; and those risks and uncertainties described under the
heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S.
Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
She'll take a leave
of absence from Gowling Lafleur Henderson LLP, where she is a partner and
head of the firm's
securities litigation practice.
Our lawyers have extensive experience in the areas
of: sexual abuse, tractor trailer and commercial vehicle
litigation, medical malpractice, wrongful death, serious auto accidents, bus accidents, dog bites, product liability, brain /
head injuries, burn and electrical injuries, spinal cord injuries, premises liability, negligent
security, and many other types
of personal injury cases.
He is a shareholder with Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor and is
head of the
Securities & Business
Litigation Department.
Head of Business Services in the Wye Valley, Arpinder Dhillon has again been named as a leader in her field, and the litigation skills of Richard Morgan, head of the firm's defence, security and the forces sector, have brought him that same sta
Head of Business Services in the Wye Valley, Arpinder Dhillon has again been named as a leader in her field, and the
litigation skills
of Richard Morgan,
head of the firm's defence, security and the forces sector, have brought him that same sta
head of the firm's defence,
security and the forces sector, have brought him that same status.
Since then, Bennett Jones» team, which includes the
head of its IP
litigation practice Dominique Hussey and corporate and
securities partner Aaron Sonshine, has worked with clients across various sectors on a range
of initial ventures during the cannabis sector's infancy.